Business / Finance RSS Feed - Business / Finance

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production. [More]
Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging. [More]
Arkin Holdings and Primera Capital lead investment of $13M in BioSight

Arkin Holdings and Primera Capital lead investment of $13M in BioSight

BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML. [More]
Oxford Nanoimaging begins sales of desktop optical microscope

Oxford Nanoimaging begins sales of desktop optical microscope

Oxford Nanoimaging commence sales of an elegant desktop optical microscope capable of zooming in on objects as tiny as structures inside living cells. This super-resolution microscope will allow scientists to watch how individual molecules perform chemical reactions in real-time. [More]
Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

Daiichi buys Japanese rights to CTL’s innovative cardiac regeneration medicine, Heartcel

Cell Therapy Ltd. today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo. [More]

ITL Virginia successfully completes three years of operation

Monday, 1 May will see ITL celebrate an important milestone, as the company marks three years since launching its US operation, ITL Virginia. [More]
Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea Biosciences Group, Inc. announced today that it had entered into an exclusive license agreement with Yale University for new technology to improve the differential diagnosis of malignant melanoma. [More]
METTLER TOLEDO named 'Best Weighing Company' and 'Best Laboratory Scale/Balance' in 2016 Reader’s Choice Awards

METTLER TOLEDO named 'Best Weighing Company' and 'Best Laboratory Scale/Balance' in 2016 Reader’s Choice Awards

Nominated by users, METTLER TOLEDO is proud to announce that it has once again been named “Best Weighing Company” and “Best Laboratory Scale/Balance” in the Weighing Review Reader’s Choice Awards. [More]
Pluristem granted two key cell therapy patents in Japan

Pluristem granted two key cell therapy patents in Japan

Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing... [More]
Binding Site to collarborate in iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial

Binding Site to collarborate in iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial

Binding Site is proud to be a key collaborator with Prof Sigurdur Kristinsson of the University of Iceland in his pivotal MGUS screening study for the forthcoming iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) trial. [More]
Epigenomics receives FDA approval for Epi proColon®

Epigenomics receives FDA approval for Epi proColon®

Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test. [More]
Oxford Gene Technology develops new FISH probes in ‘outstanding’ Innovate UK project

Oxford Gene Technology develops new FISH probes in ‘outstanding’ Innovate UK project

Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding’ award reserved for the top 10% of KTP projects. [More]
TyraTech launches award-winning head lice products, enters into French market

TyraTech launches award-winning head lice products, enters into French market

TyraTech, Inc., a life sciences technology company focused on nature-derived insect and parasite control products, announces a number of new initiatives including its expansion into the European market; the launch of a new product to complement the Vamousse range: Vamousse Lice Elimination for home cleaning; and further expansion of its distribution network in both the US and the UK. [More]
The Weizmann Institute of Science purchases novel Aeon™ 1GHz NMR system from Bruker

The Weizmann Institute of Science purchases novel Aeon™ 1GHz NMR system from Bruker

The Weizmann Institute of Science in Rehovot, Israel today announced major scientific instrument purchases from Bruker (NASDAQ: BRKR), including a novel Aeon™ 1GHz nuclear magnetic resonance (NMR) system for expanding frontiers in structural biology and intrinsically disordered protein (IDPs) research. Furthermore, the Weizmann Institute is adding an Aeon 600 MHz NMR, a 263 GHz dynamic nuclear polarization (DNP)-NMR system, and a Biospec® 15 Tesla system for preclinical ultra-high field magnetic resonance imaging (MRI). Various NMR and electron paramagnetic resonance (EPR) instrument upgrades round out this major acquisition, instantly propelling the Weizmann Institute to the frontiers of modern magnetic resonance research infrastructure. [More]
SCIEX and QPS Holdings enter collaboration to establish the BioBA solution for bioanalysis of biologics

SCIEX and QPS Holdings enter collaboration to establish the BioBA solution for bioanalysis of biologics

SCIEX, a global leader in life science analytical technologies, and QPS Holdings, LLC (QPS), a leading global full-service Contract Research Organization (CRO), today announced a collaboration to advance Hybrid LBA –LCMS, a workflow for routine biologics quantification. Under the agreement, QPS Holdings will deploy the SCIEX BioBA Solution, the first end-to-end and most complete solution for bioanalysis of biologics. [More]
Ontario to invest $4.22 million to support R&D expansion project at Baylis' Mississauga manufacturing plant

Ontario to invest $4.22 million to support R&D expansion project at Baylis' Mississauga manufacturing plant

Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company’s Mississauga manufacturing plant. [More]

BioTools forms collaborative alliance with Chiral Technologies

BioTools Inc. announced today that it has entered into a cooperative agreement with Chiral Technologies Inc., West Chester, PA, the leader in enantioselective chromatography. [More]

BioTools continues growth, expands products and services in Europe

BioTools, Inc. proudly announces the establishment of its first international subsidary, BioTools Europe, Ltd. [More]
BioAgilytix announces acquisition of IPM Biotech

BioAgilytix announces acquisition of IPM Biotech

BioAgilytix, a leading provider of contract bioanalytical testing services specializing in large molecule bioanalysis, has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity. [More]

Leica Microsystems deploys Druva inSync to protect, manage access to business data across globe

Druva, the leader in converged data protection, today announced that Leica Microsystems, a multi-national company that develops and manufactures microscopes and other scientific instruments, has deployed inSync for central protection and visibility of data stored on end-user devices. [More]
Advertisement
Advertisement